2 recruiting, 1 active not recruiting, 1 completed, 1 terminated. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 1, Completed 1, Recruiting 1, Terminated 1 |
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
Follow this drug Literature Review of Camonsertib trials Research Report on Camonsertib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma Biospecimen Collection, Camonsertib, Computed Tomography - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Recurrent Head and Neck Squamous Cell Carcinoma | Phase 1 | Recruiting | National Cancer Institute (NCI) | 39 | 2027-02-13 | 2026-09-03 |
| Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer RP-6306, Gemcitabine, Observation - Breast Cancer | Phase 2 | Recruiting | Canadian Cancer Trials Group | 484 | 2023-06-13 | 2026-05-07 |
| RP-6306 in Patients With Advanced Cancer RP-6306, Gemcitabine, FOLFIRI Protocol - Advanced Cancer | Phase 2 | Completed | Canadian Cancer Trials Group | 28 | 2023-05-24 | 2026-02-06 |
| Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study Entrectinib, Alectinib, Atezolizumab - Solid Tumors | Phase 2 | Active not recruiting | Hoffmann-La Roche | 920 | 2021-01-18 | 2026-09-04 |
| A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer) Atezolizumab, Cobimetinib, RO6958688 - Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | Terminated | Hoffmann-La Roche | 314 | 2017-12-27 | 2026-05-12 |
Breast Neoplasms (1) · Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Hypopharyngeal Neoplasms (1) · Laryngeal Neoplasms (1) · Mouth Neoplasms (1) · Oropharyngeal Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Canadian Cancer Trials Group (2) · Hoffmann-La Roche (2) · National Cancer Institute (NCI) (1)
Canada (3) · United States (3) · Australia (2) · France (2) · Israel (2) · South Korea (2) · Spain (2) · United Kingdom (2) · Belgium (1) · Brazil (1) · China (1) · Denmark (1) · Germany (1) · Hong Kong (1) · Italy (1)
David Cescon (1) · Eric Chen (1) · John Hilton (1) · Moira Rushton (1) · Nathalie Levasseur (1) · Stephanie Lheureux (1) · Stephen Chia (1) · Yvette Drew (1) · Yvonne M Mowery (1)
2017 (1), 2023 (1), UM1CA186690 (1)